ArticleCureus2026
Kaposi Sarcoma in an HIV-Negative Patient Following Temozolomide Chemoradiation Treatment for High-Grade Glioma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kaposi sarcoma is a rare vascular neoplasm caused by human herpesvirus 8 (HHV8), commonly associated with human immunodeficiency virus (HIV) infection or iatrogenic immunosuppression. This report describes the case of a 44-year-old male who recently completed chemoradiation therapy for a high-grade midline glioma who presented with a right upper eyelid lesion. Wedge resection of the lesion was performed. Microscopic examination revealed a nodular proliferation of atypical medium-sized spindled cells with numerous vascular spaces and scattered mitotic figures. Immunohistochemical staining confirmed that the atypical cells were positive for HHV8, supporting the diagnosis of Kaposi sarcoma. This case may represent an exceptionally rare example of Kaposi sarcoma in a patient with immunosuppression resulting from chemotherapy for a previously diagnosed brain tumor. This case may help inform future investigations into the molecular mechanisms of HHV8-induced cellular transformations that lead to the development of Kaposi sarcoma and may also inform future conversations on the risks and benefits of different chemotherapy regimens in high-grade glioma patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.